Expression of MMP-9 and NF-κB were also reported to be decreased in colorectal cancer cells and paclitaxel-resistant colorectal cancer cell lines (HCT116, LoVo and CT26) with ATRA treatment [94]. This evidence concerns the gene NFKB1 and colorectal cancer.